Cargando…

Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease

Targeting toxic amyloid beta (Aβ) oligomers is currently a very attractive drug development strategy for treatment of Alzheimer´s disease. Using mirror-image phage display against Aβ1-42, we have previously identified the fully D-enantiomeric peptide D3, which is able to eliminate Aβ oligomers and h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Nan, Leithold, Leonie H. E., Post, Julia, Ziehm, Tamar, Mauler, Jörg, Gremer, Lothar, Cremer, Markus, Schartmann, Elena, Shah, N. Jon, Kutzsche, Janine, Langen, Karl-Josef, Breitkreutz, Jörg, Willbold, Dieter, Willuweit, Antje
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457900/ https://www.ncbi.nlm.nih.gov/pubmed/26046986 http://dx.doi.org/10.1371/journal.pone.0128553

Ejemplares similares

The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology
por: van Groen, Thomas, et al.
Publicado: (2017)

In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease
por: Schartmann, Elena, et al.
Publicado: (2018)

In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease
por: Schemmert, Sarah, et al.
Publicado: (2021)

Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival
por: Wintz, Katharina, et al.
Publicado: (2023)

A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model
por: Post, Julia, et al.
Publicado: (2021)

Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination
por: Klein, Antonia Nicole, et al.
Publicado: (2016)

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
por: Schemmert, Sarah, et al.
Publicado: (2018)

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease
por: Kutzsche, Janine, et al.
Publicado: (2017)

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1(G93A) Transgenic Mice
por: Post, Julia, et al.
Publicado: (2021)

Sex-Related Motor Deficits in the Tau-P301L Mouse Model
por: Camargo, Luana Cristina, et al.
Publicado: (2021)

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease
por: Camargo, Luana Cristina, et al.
Publicado: (2021)

QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers
por: Brener, Oleksandr, et al.
Publicado: (2015)

Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice
por: Dunkelmann, Tina, et al.
Publicado: (2018)

Tritium-Labeled Compounds VIII. Confirmation of the Position of the Tritium in d-Glucose-6-t and d-Glucitol-5-t
por: Sniegoski, Lorna T., et al.
Publicado: (1962)

Inhibition of Polyglutamine Misfolding with D-Enantiomeric Peptides Identified by Mirror Image Phage Display Selection
por: Kolkwitz, Pauline Elisabeth, et al.
Publicado: (2022)

Do We Need Anti-Prionic Compounds to Treat Alzheimer’s Disease?
por: Willbold, Dieter, et al.
Publicado: (2019)

Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease
por: Kutzsche, Janine, et al.
Publicado: (2023)

Safety and pharmacokinetics of the orally available antiprionic compound PRI‐002: A single and multiple ascending dose phase I study
por: Kutzsche, Janine, et al.
Publicado: (2020)

Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
por: Rudolph, Stephan, et al.
Publicado: (2016)

Correction: Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
por: Rudolph, Stephan, et al.
Publicado: (2016)

Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
por: Dammers, Christina, et al.
Publicado: (2016)

Tritium-Labeled Compounds IV. d-Glucose-6-t, d-Xylose-5-t, and d-Mannitol-1-t
por: Isbell, Horace S., et al.
Publicado: (1960)

Treatment of Oral Biofilms by a D-Enantiomeric Peptide
por: Zhang, Tian, et al.
Publicado: (2016)

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies
por: Altendorf, Tim, et al.
Publicado: (2023)

Development of a Small D-Enantiomeric Alzheimer’s Amyloid-β Binding Peptide Ligand for Future In Vivo Imaging Applications
por: Funke, Susanne Aileen, et al.
Publicado: (2012)

Tritium and its compounds
por: Evans, E Anthony
Publicado: (1966)

Tritium-Labeled Compounds II. General-Purpose Apparatus, and Procedures for the Preparation, Analysis, and Use of Tritium Oxide and Tritium-Labeled Lithium Borohydride
por: Isbell, Horace S., et al.
Publicado: (1959)

Tritium-Labeled Compounds VII. Isotope Effects in the Oxidation of d-Mannitols-C(14) and d-Mannitols-t to d-Fructoses
por: Sniegoski, Lorna T., et al.
Publicado: (1961)

Fused Deposition Modeling (FDM) 3D Printing of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate
por: Hoffmann, Lena, et al.
Publicado: (2022)

Tritium: advances in research and applications
por: Janković, Marija M
Publicado: (2018)

DESY: Studies on tritium contamination
Publicado: (1972)

Tritium calorimeter setup and operation
por: Rodgers, D E
Publicado: (2002)

Tritium technology and safety at JET
por: Bell, A C
Publicado: (1994)

Tritium and helium-3 in metals
por: Lässer, Rainer
Publicado: (1989)

KATRIN: First Tritium measurements
por: Sibille, Valerian
Publicado: (2019)

Tritium-Labeled Compounds V. Radioassay of Both Carbon–14 and Tritium in Films, With a Proportional Counter
por: Isbell, Horace S., et al.
Publicado: (1960)

Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives
por: Langen, Karl-Josef, et al.
Publicado: (2023)

Low-level proportional counter for tritium
por: Charalambous, Stefano, et al.
Publicado: (1963)

Low-level proportional counter for tritium
por: Charalambous, S, et al.
Publicado: (1963)

Enrichment of tritium by diffusion through palladium
por: Charalambous, S, et al.
Publicado: (1965)

Cannot write session to /tmp/vufind_sessions/sess_o71k9gu0o032h54g52il3t8cqk